| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 10 |
| 1 | ALCOHOL | 5 |
| 2 | ETHYL ALCOHOL | 5 |
| 3 | ISOPROPYL ALCOHOL | 5 |
| 4 | ACETAMINOPHEN | 3 |
| 5 | ALPRAZOLAM | 3 |
| 6 | GABAPENTIN | 3 |
| 7 | OLANZAPINE PAMOATE | 3 |
| 8 | PREDNISONE | 3 |
| 9 | QUETIAPINE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AZATHIOPRINE SODIUM | 1 | 0.0004 |
| 1 | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | 1 | 0.0003 |
| 2 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 3 | PENTOXIFYLLINE | 1 | 0.0002 |
| 4 | CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES | 2 | 0.0002 |
| 5 | CIMETIDINE | 2 | 0.0002 |
| 6 | ETHYL ALCOHOL | 5 | 0.0002 |
| 7 | CARBOXYMETHYLCELLULOSE SODIUM | 1 | 0.0002 |
| 8 | ICATIBANT ACETATE | 1 | 0.0002 |
| 9 | NABUMETONE | 1 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Benzodiazepine [EPC] | 5 |
| 1 | Atypical Antipsychotic [EPC] | 4 |
| 2 | Corticosteroid [EPC] | 4 |
| 3 | Interleukin-23 Antagonist [EPC] | 4 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 4 |
| 5 | Opioid Agonist [EPC] | 3 |
| 6 | Amide Local Anesthetic [EPC] | 2 |
| 7 | Histamine-2 Receptor Antagonist [EPC] | 2 |
| 8 | Insulin Analog [EPC] | 2 |
| 9 | Interferon beta [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 1 | Thymic Stromal Lymphopoietin Blocker [EPC] | 1 | 0.0001 |
| 2 | RNA Synthetase Inhibitor Antibacterial [EPC] | 1 | 0.0001 |
| 3 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 4 | Interleukin-23 Antagonist [EPC] | 4 | 0.0000 |
| 5 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 6 | Sympathomimetic-like Agent [EPC] | 1 | 0.0000 |
| 7 | Amide Local Anesthetic [EPC] | 2 | 0.0000 |
| 8 | Complement Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Cholinergic Nicotinic Agonist [EPC] | 1 | 0.0000 |